Common variable immunodeficiency patients display elevated
plasma levels of granulocyte activation markers elastase and
myeloperoxidase

J 2019

Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase

LITZMAN, Jiří, Zita CHOVANCOVÁ, Petr BEJDÁK, Marek LITZMAN, Zdeněk HEL et. al.

Základní údaje

Originální název

Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase

Autoři

LITZMAN, Jiří (203 Česká republika, domácí), Zita CHOVANCOVÁ (203 Česká republika, domácí), Petr BEJDÁK (203 Česká republika, domácí), Marek LITZMAN (203 Česká republika), Zdeněk HEL (840 Spojené státy) a Marcela VLKOVÁ (203 Česká republika, garant, domácí)

Vydání

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, THOUSAND OAKS, SAGE PUBLICATIONS INC, 2019, 0394-6320

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.209

Kód RIV

RIV/00216224:14110/19:00108463

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1177/2058738419843381

UT WoS

000464236600001

Klíčová slova anglicky

CVID; elastase; immunoglobulin treatment; myeloperoxidase; neutrophil activation

Štítky

14110114, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 11. 5. 2020 09:15, Mgr. Tereza Miškechová

Anotace

V originále

Common variable immunodeficiency disorders (CVIDs) represent a group of primary immunodeficiency diseases characterized by hypogammaglobulinemia and dysfunctional immune response to invading pathogens. Previous studies have indicated that CVID is associated with microbial translocation and systemic myeloid cell activation. The goal of this study was to determine whether patients with CVID display elevated systemic levels of markers of granulocyte activation and whether the levels are further influenced by intravenous immunoglobulin (IVIg) infusions. The plasma levels of granulocyte activation markers elastase and myeloperoxidase were determined using enzyme-linked immunosorbent assay (ELISA) in 46 CVID patients and 44 healthy controls. All CVID patients were in a stable state with no apparent acute infection. In addition, granulocyte activation markers' plasma levels in 24 CVID patients were determined prior to and 1 h following IVIg administration. Neutrophil elastase and myeloperoxidase plasma levels were significantly higher in CVID patients than in healthy controls. Systemic elastase levels were further increased following IVIg administration. In vitro stimulation of 13 CVID patients' whole blood using IVIg in a therapeutically relevant dose for 2 h resulted in a significant increase in plasma elastase levels compared to unstimulated blood. The data presented here indicate that CVID is associated with chronic granulocytic activation which is further exacerbated by administering IVIg. Increased myeloperoxidase and elastase levels may contribute to associated comorbidities in CVID patients.

Návaznosti

NV15-28732A, projekt VaV

Název: Vliv granulocytů a monocytů na vznik a rozvoj imunodeficitních chorob a dalších imunopatologických dějů

Citovat

LITZMAN, Jiří, Zita CHOVANCOVÁ, Petr BEJDÁK, Marek LITZMAN, Zdeněk HEL a Marcela VLKOVÁ. Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. THOUSAND OAKS: SAGE PUBLICATIONS INC, 2019, roč. 33, UNSP 2058738419843381, s. 1-10. ISSN 0394-6320. Dostupné z: https://dx.doi.org/10.1177/2058738419843381.

@article{1527055,
   author = {Litzman, Jiří and Chovancová, Zita and Bejdák, Petr and Litzman, Marek and Hel, Zdeněk and Vlková, Marcela},
   article_location = {THOUSAND OAKS},
   article_number = {UNSP 2058738419843381},
   doi = {http://dx.doi.org/10.1177/2058738419843381},
   keywords = {CVID; elastase; immunoglobulin treatment; myeloperoxidase; neutrophil activation},
   language = {eng},
   issn = {0394-6320},
   journal = {INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY},
   title = {Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase},
   url = {http://dx.doi.org/10.1177/2058738419843381},
   volume = {33},
   year = {2019}
}

TY  - JOUR
ID  - 1527055
AU  - Litzman, Jiří - Chovancová, Zita - Bejdák, Petr - Litzman, Marek - Hel, Zdeněk - Vlková, Marcela
PY  - 2019
TI  - Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase
JF  - INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
VL  - 33
IS  - UNSP 2058738419843381
SP  - 1-10
EP  - 1-10
PB  - SAGE PUBLICATIONS INC
SN  - 03946320
KW  - CVID
KW  - elastase
KW  - immunoglobulin treatment
KW  - myeloperoxidase
KW  - neutrophil activation
UR  - http://dx.doi.org/10.1177/2058738419843381
L2  - http://dx.doi.org/10.1177/2058738419843381
N2  - Common variable immunodeficiency disorders (CVIDs) represent a group of primary immunodeficiency diseases characterized by hypogammaglobulinemia and dysfunctional immune response to invading pathogens. Previous studies have indicated that CVID is associated with microbial translocation and systemic myeloid cell activation. The goal of this study was to determine whether patients with CVID display elevated systemic levels of markers of granulocyte activation and whether the levels are further influenced by intravenous immunoglobulin (IVIg) infusions. The plasma levels of granulocyte activation markers elastase and myeloperoxidase were determined using enzyme-linked immunosorbent assay (ELISA) in 46 CVID patients and 44 healthy controls. All CVID patients were in a stable state with no apparent acute infection. In addition, granulocyte activation markers' plasma levels in 24 CVID patients were determined prior to and 1 h following IVIg administration. Neutrophil elastase and myeloperoxidase plasma levels were significantly higher in CVID patients than in healthy controls. Systemic elastase levels were further increased following IVIg administration. In vitro stimulation of 13 CVID patients' whole blood using IVIg in a therapeutically relevant dose for 2 h resulted in a significant increase in plasma elastase levels compared to unstimulated blood. The data presented here indicate that CVID is associated with chronic granulocytic activation which is further exacerbated by administering IVIg. Increased myeloperoxidase and elastase levels may contribute to associated comorbidities in CVID patients.
ER  -

LITZMAN, Jiří, Zita CHOVANCOVÁ, Petr BEJDÁK, Marek LITZMAN, Zdeněk HEL a Marcela VLKOVÁ. Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase. \textit{INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY}. THOUSAND OAKS: SAGE PUBLICATIONS INC, 2019, roč.~33, UNSP 2058738419843381, s.~1-10. ISSN~0394-6320. Dostupné z: https://dx.doi.org/10.1177/2058738419843381.

Podrobný výpis o publikaci